Taylor, Cottrill, Erickson & Associates, Inc. Eli Lilly & CO Transaction History

Taylor, Cottrill, Erickson & Associates, Inc.

  • $359 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022
SELL
$224.85 - $279.04 $577,189 - $716,295
-2,567 Closed
0 $0
Q3 2021

Oct 15, 2021
BUY
$221.6 - $272.71 $155,120 - $190,897
700 Added 37.49%
2,567 $593,000
Q3 2020

Oct 09, 2020
SELL
$146.22 - $169.13 $7,164 - $8,287
-49 Reduced 2.56%
1,867 $276,000
Q2 2020

Jul 14, 2020
BUY
$136.42 - $164.18 $6,684 - $8,044
49 Added 2.62%
1,916 $315,000
Q4 2018

Jan 29, 2019
BUY
$105.9 - $118.64 $197,715 - $221,500
1,867 New
1,867 $216,000

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Taylor, Cottrill, Erickson & Associates, Inc. Portfolio

Follow Taylor, Cottrill, Erickson & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email